Recent

% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • jsblvbjb jsblvbjb Apr 8, 2013 8:37 AM Flag

    Two horses that will race into October...

    PRKR vs. INSM
    Remeber when the Markman hearing went against Insmed? We tried to ignore the obvious dire straights that Insmed was in based on our own focus to the reality of Iplex. Well, Parker has kicked QCOM's butt in the Markman on 90 patents! And treble damages are a distinct possibility. PRKR hasn't had any revenues for all these years because QCOM stole their technology and then profited to the tune of billions in cell phone chip production.
    Back to Insmed: In the same timeframe as PRKR's potential big win, we are going to get Arikace data from the phase 3, Russell inclusion and possibly news on the Iplex/premiplex front that produces revenue. Also, Arikace is going to become available in the 2nd half of this year on a Compassionate Use basis, ahead of potential FDA approval, also creating revenue.
    I see both these stocks reaching at least 20 if everything falls into place, but Insmed has even less risk, IMO.
    pianoman

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
INSM
12.15-0.31(-2.49%)Apr 29 4:00 PMEDT